Show simple item record

dc.contributor.authorChinembiri, Tawona N.
dc.contributor.authorGerber, Minja
dc.contributor.authorDu Plessis, Lissinda H.
dc.contributor.authorDu Preez, Jan L.
dc.contributor.authorHamman, Josias H.
dc.contributor.authorDu Plessis, Jeanetta
dc.date.accessioned2017-10-23T06:09:04Z
dc.date.available2017-10-23T06:09:04Z
dc.date.issued2017
dc.identifier.citationChinembiri, T.N. et al. 2017. Topical delivery of Withania somnifera crude extracts in niosomes and solid lipid nanoparticles. Pharmacognosy magazine, 13(51):663-671. [https://doi.org/10.4103/pm.pm_489_16]en_US
dc.identifier.issn0973-1296
dc.identifier.issn0976-4062 (Online)
dc.identifier.urihttp://hdl.handle.net/10394/25904
dc.identifier.urihttps://doi.org/10.4103/pm.pm_489_16
dc.description.abstractBackground: Withania somnifera is a medicinal plant native to India and is known to have anticancer properties. It has been investigated for its anti-melanoma properties, and since melanoma presents on the skin, it is prudent to probe the use of W. somnifera in topical formulations. To enhance topical drug delivery and to allow for controlled release, the use of niosomes and solid lipid nanoparticles (SLNs) as delivery vesicles were explored. Objective: The objective of this study is to determine the stability and topical delivery of W. somnifera crude extracts encapsulated in niosomes and SLNs. Materials and Methods: Water, ethanol, and 50% ethanol crude extracts of W. somnifera were prepared using 24 h soxhlet extraction which were each encapsulated in niosomes and SLNs. Franz cell diffusion studies were conducted with the encapsulated extracts to determine the release and skin penetration of the phytomolecules, withaferin A, and withanolide A. Results: The niosome and SLN formulations had average sizes ranging from 165.9 ± 9.4 to 304.6 ± 52.4 nm with the 50% ethanol extract formulations having the largest size. A small particle size seemed to have correlated with a low encapsulation efficiency (EE) of withaferin A, but a high EE of withanolide A. There was a significant difference (P < 0.05) between the amount of withaferin A and withanolide A that were released from each of the formulations, but only the SLN formulations managed to deliver withaferin A to the stratum corneum-epidermis and epidermis-dermis layers of the skin. Conclusion: SLNs and niosomes were able to encapsulate crude extracts of W. somnifera and release the marker compounds, withaferin A, and withanolide A, for delivery to certain layers in the skin. Abbreviations used: API: Active pharmaceutical ingredient, ANOVA: Analysis of variance, ED: Epidermis-dermis, HPLC: High-performance liquid chromatography, HLB: Hydrophilic-lipophilic balance, NMR: Nuclear magnetic resonance spectroscopy, PDI: Polydispersity index, SLN: Solid lipid nanoparticle, SD: Standard deviation, SCE: Stratum corneum-epidermis, TEM: Transmission electron microscopyen_US
dc.language.isoenen_US
dc.publisherMedknowen_US
dc.subjectAshwagandha
dc.subjectNiosomes
dc.subjectSkin diffusion
dc.subjectSolid lipid nanoparticles
dc.subjectStability
dc.subjectTape-stripping
dc.subjectWithania somnifera
dc.titleTopical delivery of Withania somnifera crude extracts in niosomes and solid lipid nanoparticlesen_US
dc.typeArticleen_US
dc.contributor.researchID20945175 - Chinembiri, Tawona Nyasha
dc.contributor.researchID10065318 - Du Plessis, Jeanetta
dc.contributor.researchID10060510 - Du Preez, Jan Lourens
dc.contributor.researchID11329025 - Gerber, Minja
dc.contributor.researchID10081097 - Hamman, Josias Hendrik
dc.contributor.researchID11948388 - Du Plessis, Lissinda Hester


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record